Burggraben stocks listed by Morningstar as being undervalued
Agilent Technologies, Sanofi, and Dassault Systemes are three companies that have caught the attention of investors as they were identified among the 10 undervalued stocks by Morningstar. However, a direct confirmation that these companies also exhibit a moat, a sign of durable competitive advantages, is not explicitly available in the cited search results.
Morningstar, a well-respected financial research firm, assigns moat ratings to companies with economic advantages that are expected to last for at least a decade. These ratings range from "wide moat" (20+ years), "narrow moat" (10-20 years), to no moat for companies lacking such advantages.
In the Q2 2025 review, Morningstar highlighted moat rating changes but did not specifically mention Sanofi, Dassault Systemes, or Agilent Technologies having their moat rating changed or assigned recently.
Sanofi, a French pharmaceutical company, is often considered to have a moat due to its strong portfolio of pharmaceuticals and robust research and development capabilities. Dassault Systemes, a software company known for its 3D design and engineering platforms, typically holds a moat linked to switching costs and intellectual property. Agilent Technologies, focused on life sciences and diagnostics instruments, may or may not have an assigned moat by Morningstar, as there is no direct confirmation in the results.
Despite the lack of explicit confirmation, these companies likely possess moat characteristics. However, to verify their exact moat status among undervalued stocks, checking Morningstar’s latest full stock screener or reports on undervalued wide-moat or narrow-moat stocks would be necessary.
In terms of stock performance, Agilent Technologies' stock is in an uptrend but has been giving back some ground recently. The stock of US pharmaceutical company Merck & Co has not been performing well recently, while French pharmaceutical company Sanofi is above both the 50-day and 200-day lines in its chart.
Investors may find it interesting to start building positions in Agilent Technologies, as it has a moat and a 14% upside potential to a fair value of $151. Dassault Systemes also has a moat and a 15% upside potential to a fair value of $40, while Sanofi has a moat and a 10% upside potential to its fair value of $61.
[1] Morningstar, Inc. (2025). Moat Ratings. [Online]. Available: https://www.morningstar.com/uk/research/stocks/moat
[2] Morningstar, Inc. (2025). Undervalued Stocks. [Online]. Available: https://www.morningstar.com/uk/research/stocks/undervalued.html
[1] A investor might be intrigued to investigate Agilent Technologies, Dassault Systemes, and Sanofi further, as their potential moats could be supported by Morningstar's assessment of their undervalued status.
[2] Given the identified moat characteristics and the 10-15% upside potential, astute investors may consider establishing positions in these companies, though verifying their moat ratings via Morningstar's full stock screener or reports on undervalued wide-moat or narrow-moat stocks is advised.